Stockscreener 앱 받기
2.52
5.26%
-0.14
시간 외 거래:
2.49
-0.03
-1.19%
전일 마감가:
$2.66
열려 있는:
$2.7
하루 거래량:
31,645
Relative Volume:
1.72
시가총액:
$178.49M
수익:
-
순이익/손실:
$-2.97M
주가수익비율:
-2.5506
EPS:
-0.988
순현금흐름:
$-1.18M
1주 성능:
-18.84%
1개월 성능:
-51.30%
6개월 성능:
-80.06%
1년 성능:
+0.00%
1일 변동 폭
$2.4501
$2.8799
1주일 범위
$2.45
$3.58
52주 변동 폭
$2.45
$25.00
Yd Bio Ltd Stock (YDES) Company Profile
Compare YDES vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
YDES
Yd Bio Ltd
|
2.52 | 240.13M | 0 | -2.97M | -1.18M | -0.988 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Yd Bio Ltd 주식(YDES)의 최신 뉴스
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
[EFFECT] YD Bio Ltd SEC Filing - Stock Titan
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview - Yahoo Finance
YD Bio Stock Is Falling Again: The SEC Filing Behind the Slide - Bez Kabli
iGan Partners Invests in Adenocyte Ltd to Advance the Early Detection of Pancreatic Cancer - Yahoo Finance
YD Bio (NASDAQ: YDES) prospectus lists 58.6M resale shares, 11.4M exercisable - Stock Titan
Ingenia Therapeutics, a Clinical-Stage Biotechnology Company, Has Received Approval for an Initial Public Offering on the Korea Exchange (KRX) - Yahoo Finance
Registrar Corp and U.S. Commercial Service Strengthen Partnership to Support Australian Companies Expanding into the U.S. - Yahoo Finance
Yourgene Health Launches Insight DPYD Assay - Yahoo Finance
Affiliated (MGRE) Steady at $$24.02 — Awaiting Next Catalyst 2026-05-13Rip Sell Trade - The Legal Advocate
YD Bio Limited Ordinary Shares Stock Forecast Summary - Meyka
Autoliv posts upbeat Q1 results, joins United Airlines, Royal Caribbean Cruises and other big stocks moving higher on Friday - MSN
YD Bio Limited Reports Full Year 2025 Financial Results - ChartMill
YD Bio Limited Reports Financial Results for Full Year 2025, Achieves 17% Revenue Growth and Strategic Advances in Healthcare Innovations - Quiver Quantitative
YD Bio 2025 Loss/Shr 12c >YDES - Moomoo
After a $13.9M equity raise, YD Bio enters 2026 with $6M cash - Stock Titan
Going concern warning tops YD Bio (NASDAQ: YDES) 20-F risk disclosures - Stock Titan
ClearNote Health to Present Industry-Leading Early Detection Data for Avantect® Pancreatic Cancer Test at Digestive Disease Week 2026 - Yahoo Finance
New LowStock ScreenerSnapshot - Finviz
Immuneering Corp (IMRX) Stock Price, Quote, News & History - Benzinga
CMMB (Chemomab Therapeutics Ltd. American Depositary Share) posts narrower Q4 2025 loss than estimates, while shares dip modestly.Community Trade Ideas - Xã Thanh Hà
What is happening with Elbit Systems (ESLT) stock today (Smart Money Active) 2026-04-20High Interest Stocks - Cổng thông tin điện tử tỉnh Lào Cai
[Form 3/A] YD Bio Ltd Amended Initial Statement of Beneficial Ownership - Stock Titan
Shao Ta Lu Net Worth (2026) - GuruFocus
Autoliv Posts Upbeat Q1 Results, Joins United Airlines, Royal Caribbean Cruises And Other Big Stocks Moving Higher On Friday - Sahm
Man Edmund Hen Net Worth (2026) - GuruFocus
Bo Xiang Zhang Net Worth (2026) - GuruFocus
Autoliv Posts Upbeat Q1 Results, Joins United Airlines, Royal Caribbean Cruises And Other Big Stocks Movi - Benzinga
GFL ENVIRONMENTAL INC. (GFL) - MSN
How does macroeconomics affect YD Bio (YDES) Stock | Price at $5.97, Down 4.57%Portfolio Management - newser.com
Is YD Bio (YDESW) Stock slowing down | Price at $0.58, Down 10.08%Market Hype Signals - Newser
Bora Biologics Successfully Completes 2,000L Engineering and Scale-Up Run in San Diego, Reinforcing Commercial-Scale Readiness - Yahoo Finance
YDES Technical Analysis & Stock Price Forecast - Intellectia AI
YDES SEC FilingsYD Bio Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
CRVL Stock Analysis: CorVel Corp. notches 1.6 pct daily gain near 54 key support - The Legal Advocate
YD Bio (YDES) director receives $60,000 RSU grant and 2,081 shares - Stock Titan
Director at YD Bio (YDES) receives $60K RSU equity award - Stock Titan
YD Bio (NASDAQ: YDES) director Lu Shao-Ta files initial Form 3 - Stock Titan
Director Chang Kochi logs initial insider status at YD Bio Ltd (YDES) - Stock Titan
YD Bio launches telehealth platform for cancer detection By Investing.com - Investing.com South Africa
YD Bio launches telehealth platform for cancer detection - Investing.com
YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States - The Manila Times
Yd Bio Limited and Eg Biomed Co., Ltd. Launch Nationwide Telehealth Platform - marketscreener.com
Cancer test platform goes live in 44 states, D.C. and Guam - Stock Titan
YD Bio (YDES) director files Form 3 with no share activity - Stock Titan
Stock List: Research Stocks from Around the World - GuruFocus
[Form 3] YD Bio Ltd Initial Statement of Beneficial Ownership - Stock Titan
[Form 3] YD Bio Ltd Initial Statement o... - Stock Titan
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Rise Nano Optics Announces FDA Class I Device Classification for SPECTRAGUARD(TM) Nano-Optic Lens Technology - Yahoo Finance
YD Bio details roadmap for integrated oncology ecosystem - tipranks.com
Yd Bio Ltd (YDES) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.60%
0.94%
자본화:
|
볼륨(24시간):